Navigation Links
EmergingMed Granted Patent
Date:6/3/2010

;"EmergingMed is instrumental in providing comprehensive support to people affected by cancer through their unique clinical trials education and matching program, their commitment to the cancer community, and their ability to respond to the needs of those affected by cancer."  

EmergingMed's phone and web-based matching system is featured by more than 50 patient advocacy organizations, pharmaceutical and biotech companies, and medical centers including Lance Armstrong Foundation, Pfizer, Genentech, AstraZeneca, EMD Serono, Enzon, CarisMPI, Ohio State University, the State of Florida, and POETIC.

"Trial sponsors and research sites utilize EmergingMed's customized solutions to find targeted patient populations, to ensure routine prescreening of all patients, and to analyze the suitability of their clinical trials for their specific patient populations," added Courtney Hudson, CEO.  "Our long-term follow-up with patients allows us to track outcomes, identify barriers, and empower patients to consider clinical trials each time a treatment decision is needed."  

EmergingMed said that although it will vigorously protect its intellectual property rights, it is seeking to broadly distribute its matching services beyond oncology to include other disease areas.

About EmergingMed

EmergingMed provides personalized clinical trial matching, referral support, education and long-term follow-up with patients on behalf of patient advocacy organizations, medical centers, pharmaceutical & biotech companies, and the State of Florida. Founded in 2000, EmergingMed has offices in New York, NY and Durham, NC.   For
'/>"/>

SOURCE EmergingMed
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. Pharmions Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
3. PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
4. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
5. ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office
6. Odyssey Thera Granted U.S. Patent for Animal Imaging
7. Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis
8. Kiwa Bio-Tech New Bio-Fertilizer Product Granted Initial Fertilizer Registration Certificate By Ministry of Agriculture of the PRC
9. Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications
10. Genta Granted Extension to Achieve Compliance with NASDAQ Listing Requirements
11. Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... work by a Florida State University research team has ... your temperature, emit white light, and convert photon energy ... like a butterfly. , Biwu Ma, associate professor in ... FAMU-FSU College of Engineering, created the molecule in a ... discover that his creation has many other unique capabilities. ...
(Date:8/28/2014)... Earlier this month, a report was ... the U.S. Air Force on the performance of vehicles ... this type of fuel made from mustard seeds, offered ... to America’s Eco friendly future. In fact, every branch ... become independent of foreign oil over the next few ...
(Date:8/28/2014)... 2014 Whitehouse Laboratories is excited to ... with PTI Inspection Systems that will enable ... the art leak testing method development and validation programs ... available. As part of this agreement, Whitehouse Labs has ... Detection Instrument developed and manufactured by PTI. The ...
(Date:8/27/2014)... -- Rhythm, a biopharmaceutical company developing peptide therapeutics that ... metabolic disorders, announced today that it has filed a ... and Exchange Commission (SEC) relating to the proposed initial ... number of shares to be offered and the price ... Citigroup and Cowen and Company will act ...
Breaking Biology Technology:Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 2Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 3Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 4Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 5Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Rhythm Files Registration Statement for Proposed Initial Public Offering 2
... Hosts Three Customer Audits, Continues Growth Strategy ... Industry-Leading Software Tools, MOUNTAIN VIEW, Calif., Dec. ... leading provider of software, strategic,consulting, and regulatory services ... global biopharmaceutical companies,have performed audits of its Reporting ...
... ... - Lead compound AEG40826 works synergistically with HGS TRAIL receptor ... -, - IAP inhibitors also show promise alone and in combination ... agents across broad range of cancers -, ROCKVILLE, Md. and MONTREAL, Quebec, ...
... 20 Human Genome,Sciences, Inc. (Nasdaq: HGSI ... patients in a Phase 2 clinical trial of ... and carboplatin as,first-line therapy in patients with advanced ... patients who are newly diagnosed with non-small cell,lung ...
Cached Biology Technology:Pharsight's Reporting and Analysis Services Business Reaches Quality Assurance Milestone 2Pharsight's Reporting and Analysis Services Business Reaches Quality Assurance Milestone 3Pharsight's Reporting and Analysis Services Business Reaches Quality Assurance Milestone 4Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 2Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 3Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 4Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 5Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 6Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy 2Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy 3Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy 4Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy 5Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy 6
(Date:8/27/2014)... Using functional near infrared spectroscopy (fNIRS), Kessler Foundation ... people with multiple sclerosis (MS) and healthy controls. ... brain activation was studied using fNIRS while participants ... cognition using functional near infrared spectroscopy (fNIRS) in ... by Brain Imaging and Behavior . Authors ...
(Date:8/27/2014)... 400 million years ago a group of fish began exploring ... and mammals. But just how these ancient fish used their ... evolutionary processes were at play remain scientific mysteries. , ... , turned to a living fish, called Polypterus , ... attempted to walk out of the water. Polypterus ...
(Date:8/27/2014)... is easier when it is related to ability that ... learn a new melody more easily than learning how ... the Center for the Neural Basis of Cognition (CNBC)a ... Mellon Universityhave discovered a fundamental constraint in the brain ... cover story in the Aug. 28, 2014, issue of ...
Breaking Biology News(10 mins):Kessler Foundation researchers publish first study of brain activation in MS using fNIRS 2Walking fish reveal how our ancestors evolved onto land 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 3
... PARK, MD, April 7, 2009 -- Roughly 20 percent ... homes, businesses, and other private and public spaces. Though ... also presents a tremendous opportunity for savings. Improving the ... little -- could translate into dramatically lower energy usage ...
... microbes that live within the plumbing of deep-sea mud ... resemble those in extraterrestrial environments and early Earth. The ... Foundation (NSF), was conducted in an area where clusters ... that support food chains independently of the Sun. ...
... researcher, Dr. Mark Flynn,s high-speed flywheel motor controller is ... the world. Flynn,s design has been incorporated into energy ... and sold by VYCON Inc. The 8,000 RTG ... significantly to port emissions and, as such, have ...
Cached Biology News:Cheap and efficient white light LEDs new design described in AIP's Journal of Applied Physics 2Cheap and efficient white light LEDs new design described in AIP's Journal of Applied Physics 3Better living through chemistry 2Better living through chemistry 3Saving energy and the environment with Flywheels 2
Mouse monoclonal [AE3] to Cytokeratin 1 - 8, prediluted ( Abpromise for all tested applications). Antigen: Tissue / cell preparation - Human epidermal cells. Entrez GeneID: 140807 Swiss P...
pETDuet-1 is designed for the coexpression of two target genes....
...
WIF-1 (N-20)...
Biology Products: